Zasady antybiotykoterapii chorob ukladu oddechowego swin

• Autorzy: Bednarek D , Pejsak Z.

Warianty tytułu

EN

Principles of antibiotic therapy in swine respiratory diseases

• Języki publikacji: PL

Abstrakty

EN

The article describes different types and generations of antibiotics and their application in the therapy of swine respiratory diseases. It reviews the present state of knowledge regarding the mode of action, recommended usage and pharmacokinetic properties of antibiotics administered mostly in trial cases of infectious respiratory problems in pigs. The routine use of antibiotics in veterinary practice is presented above all in respect to their antibacterial efficacy in treating the main pathogens of porcine respiratory tracts and their clinical efficacy. The article also describes advanced developments in new directions of antibiotic therapy. The antibacterial drugs presented in it have been selected mainly from the point of view of their utility in the treatment and prophylaxis of PRDC, pleuropneumonia, and mycoplasm infections in pigs. The article also gives a broad description of the potential risks involved with the rise of drug-resistance as the result of incorrect antibiotic applications, and new perspectives in counteracting this phenomena.

Słowa kluczowe

PL

antybiotyki nowej generacji; trzoda chlewna; pasze lecznicze; zastosowanie; antybiotyki; antybiotyki o przedluzonym dzialaniu; leczenie; choroby ukladu oddechowego; choroby zwierzat

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 02
• Opis fizyczny: s.140-144,tab.,bibliogr.

Twórcy

autor

Bednarek D

• Panstwowy Instytut Weterynaryjny-Panstwowy Instytut Badawczy, Al.Partyzantow 57, 24-100 Pulawy

autor

Pejsak Z.

Bibliografia

• 1.Aarestrup F. M., Seyfarth A. M., Angen O.: Antimicrobial susceptibility of Haemophilus parasuis and Histhophilus somni from pig and cattle in Denmark. Vet. Microb. 2003, 101, 143-146.
• 2.Allison G. S.: Elimination of Actinobacillus pleuropneumoniae utilizing whole-herd tilmicosin therapy. Proc. 18th IPSV Congress, Hamburg 2004, 1, 184.
• 3.Andersen L. V., Gram S.: A successful elimination Actinobacillus pleuropneumoniae (serotype 2), Mycoplasma hyopneumonia and PRRS (european and vaccine-strain) by partial depopulation, early weaning and tilmicosin (Pulmotil®, Elanco) treatment. Proc. 18th IPSV Congress, Hamburg 2004, 1, 179.
• 4.Berro R. M., Mendoza A. S.: Sensitivity results using florfenicol (Nuflor) against common swine pathogens. Proc. 18th IPSV Congress, Hamburg 2004, 2, 558.
• 5.Burton P. J., Thornsberry C., Cheung Y. Y., Watts J. L., Yancey R. J.: Interpretive criteria for antimicrobial susceptibility testing of ceftiofur against bacteria associated with swine respiratory disease. J. Vet. Diagn. Invest. 1996, 8, 464-468.
• 6.Cywińska A.: Tulatromycyna (Draxxin, Pfizer Animal Health) - nowy antybiotyk do leczenia chorób układu oddechowego u świń i bydła. Życie Wet. 2004, 74, 567-570.
• 7.Etore F., Bonnier M., de Haas V., Shuster D.: Bactericidal kinetics of florfenicol in swine pathogens. Proc. 18th IPSV Congress, Hamburg 2004, 2, 507.
• 8.Halbur P., Thanawongnuwech R., Brown G., Kinyon J., Roth J., Thacker E., Thaker B.: Efficacy of antimicrobial treatments and vaccination regiments for control of porcine reproductive and respiratory syndrome virus and Streptococcus suis coinfection of nursery pigs. J. Clin. Microb. 2000, 38, 1156-1160.
• 9.Hibbard B., Robinson J. A., Bryson W. I., Callahan J. K., Prough M. J., Flook T. F., Cox T. D., Catshaw P. J., Smit K. D., Newland A. R., Crane J. P.: Pharmacokinetics of ceftiofur crystalline free acid in swine. Proc. 18th IPSV Congress, Hamburg 2004, 2, 555.
• 10.Klockiewicz M.: Preparat NaxcelTM zmienia sposób leczenia świń. Życie Wet. 2005, 80, 645-649.
• 11.Kołodziejczyk P., Karbowiak S., Arh J.: Skuteczność Floronu® inj. w terapii zespołu zaburzeń oddechowych świń (PRDC) w fermie wielkotowarowej. Magazyn Wet. Suplement - Świnie 2003, 69-71.
• 12.Kowalski C., Zań R., Roliński Z.: Pochodne pleuromutyliny i ich zastosowanie w lecznictwie weterynaryjnym. Medycyna Wet. 2004, 60, 22-26.
• 13.Lewicki J., Sztabińska-Koncka.: Fluorochinolony: nowe leki przeciwbakteryjne. Leki Wet. 1996, 1, 7-13.
• 14.Löscher W., Ungemach F. R., Kroker R.: Pharmakotherapie bei Haus- und Nutztieren. Blackwell Wissenschafts-Verlag, Berlin-Wien 1999, s. 237.
• 15.Nanjiani I. A., McKelvie J., Benchaoui H. A., Sherington J., Weatherley J., Sunderland S. J.: Evaluation of tulathromycin (Draxxin®) in the treatment of swine respiratory disease on farms in Europe. Proc. 18th IPSV Congress, Hamburg 2004, 2, 554.
• 16.Nutsch R. G., Hart F. J., Kilgore R. W., Meinert T. R., Sunderland S., Lechtenberg K. F.: Comparative efficacy of tulathromycin (Draxxin® sterile solution) and ceftiofur (Naxcel® sterile powder) for treating experimental swine respiratory disease caused by Actinobacillus pleuropneumoniae. Proc. 18th IPSV Congress, Hamburg 2004, 1, 176.
• 17.Stockhofe-Zurwieden N., Wisselink H. J., Bryson W. I., Crane J. P., Van de Eede C.: Efficacy of ceftiofur crystalline free acid administered at a single intramuscular dose for the treatment of Streptococcus suis infectiones in pigs in a challenge model. Proc. 18th IPSV Congress, Hamburg 2004, 2, 512.